References

Unresolved reference

External reference

10.4081/oncol.2019.410

10.4081/oncol.2019.410 · External reference

Biomarker panel for the diagnosis of pancreatic ductal adenocarcinoma

2020 · External reference

CA19-9 on postoperative surveillance in pancreatic ductal adenocarcinoma: predicting recurrence and changing prognosis over time

10.1245/s10434-018-6521-7 · 2018 · External reference

10.1200/jco.2005.19.711

10.1200/jco.2005.19.711 · External reference

Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes

2018 · External reference

Pancreatic cancer insights: optimization of the diagnostic capacity of tumor biomarkers

10.1093/labmed/lmab016 · 2021 · External reference

Diagnostic value of CA 19-9 and carcinoembryonic antigen for pancreatic cancer: a meta-analysis

10.1155/2018/8704751 · 2018 · External reference

10.1084/jem.122.3.467

10.1084/jem.122.3.467 · External reference

10.1016/j.csbj.2019.06.005 · Admitted local publication

10.18632/oncotarget.14957

10.18632/oncotarget.14957 · External reference

10.1016/j.ccr.2012.12.001

10.1016/j.ccr.2012.12.001 · External reference

10.1101/gad.314351.118

10.1101/gad.314351.118 · External reference

Hsa_circRNA_100146 promotes prostate cancer progression by upregulating TRIP13 via sponging miR-615-5p

10.3389/fmolb.2021.693477 · 2021 · External reference

DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer

10.1002/1878-0261.13201 · 2022 · External reference

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway

10.3892/or.2023.8521 · 2023 · External reference

Trip13 depletion in liver cancer induces a lipogenic response contributing to plin2-dependent mitotic cell death

2022 · External reference

10.1158/0008-5472.can-18-3987

10.1158/0008-5472.can-18-3987 · External reference

Using evolutionary data to make sense of macromolecules with a "face-lifted" ConSurf

10.1002/pro.4582 · 2023 · External reference

ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information

2003 · External reference

10.1016/j.csbj.2023.04.029 · Admitted local publication

Unresolved reference

External reference

10.1093/nar/gkz430

10.1093/nar/gkz430 · External reference

Using evolutionary data to make sense of macromolecules with a "face-lifted" ConSurf

10.1002/pro.4582 · 2023 · External reference

CEACAM7 expression contributes to early events of pancreatic cancer

2023 · External reference

10.1093/nar/gkx1090

10.1093/nar/gkx1090 · External reference

Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma

10.1016/j.tranon.2023.101686 · 2023 · External reference

A topography of immunotherapies against gastrointestinal malignancies

10.23736/s0031-0808.21.04541-9 · 2022 · External reference

Evaluating metabolite-based biomarkers for early diagnosis of pancreatic cancer: a systematic review

10.3390/metabo13070872 · 2023 · External reference

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching

2015 · External reference

Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer

10.1371/journal.pone.0113023 · 2014 · External reference

Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning

10.1038/s43856-023-00237-5 · 2023 · External reference

Immunohistochemical evaluation of the expression of specific membrane antigens in patients with pancreatic ductal adenocarcinoma

10.3390/cancers15184586 · 2023 · External reference

Clinicopathological characteristics and prognosis of diffuse large B-cell lymphoma in relation to CA-125 and CA 19-9 expression

2023 · External reference

What is new in cancer-associated fibroblast biomarkers?

10.1186/s12964-023-01125-0 · 2023 · External reference

10.1002/1878-0261.12807

10.1002/1878-0261.12807 · External reference

Virus-driven carcinogenesis

10.3390/cancers13112625 · 2021 · External reference

10.1016/j.trecan.2018.11.003

10.1016/j.trecan.2018.11.003 · External reference

10.1016/j.bbcan.2019.05.006

10.1016/j.bbcan.2019.05.006 · External reference

Modulating pyrimidine ribonucleotide levels for the treatment of cancer

10.1186/s40170-020-00218-5 · 2020 · External reference

The role of Th17 cells in the pathogenesis and treatment of breast cancer

10.1186/s12935-022-02528-8 · 2022 · External reference